PER 13.0% 13.0¢ percheron therapeutics limited

Ann: Quarterly Update and Appendix 4C, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,642 Posts.
    lightbulb Created with Sketch. 790
    Very well said Sam..

    Akki likes cash in bank but that wont be any good without some decent trial results. We need to understand how important these results are for the DMD patients and the DMD market. Yes, the trial was small but the results are very very encouraging as the experts suggest in their opinion.

    Would be good if ANP worked on something that you suggested in stead of giving away the whole farm but then there are big predators out there who wouldn't let go of ANP and they would want it for super bargain...

    All depends on managements negotiating skills. We know MD is not capable or hasn't done any deals before hence its a new experience for him. Probably that is the reason they are planning to have someone on board with negotiating skills or experience in similar deals.

    Its just wait and watch for us as this story unfolds.

    No dumping on the market so far which is good..

    All imo
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.